Capital eventCH· 7d ago
ADC Therapeutics raises $86.6M to fund lymphoma trials, extend runway to 2029 | Dealroom News
ADC Therapeutics raised $86.6 million in a private placement, led by Bain Capital Life Sciences, to fund lymphoma trials and extend runway to 2029, with participation from existing backers Redmile and TCGX.
Sponsored
Launch your RWA with Curio
Tokenize your real-world asset with Curio
Intent
WARM· 56intent / 100
ADC Therapeutics
companyCH
Daily 5 RWA signals
Five signals in your inbox each morning. Email only.
Free. The daily 5 lands at 07:00 UTC, nothing else. One-click unsubscribe in every email.